Akshay Sood to North America
This is a "connection" page, showing publications Akshay Sood has written about North America.
Connection Strength
0.404
-
Bertini A, Stephens A, Finocchiaro A, Silvia V, Arjun D, Elnaz G, Nicholas C, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. Association of Area of Deprivation Index With Active Surveillance (AS) Utilization and Adherence to as Guidelines: Results From a Contemporary North American Cohort. Prostate. 2025 Aug; 85(11):1024-1035.
Score: 0.057
-
Cirulli GO, Stephens A, Chiarelli G, Finati M, Bertini A, Chase M, Tinsley S, Arora S, Sood A, Lughezzani G, Buffi N, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer Diagnosis: Analysis of a Contemporary North American Cohort. Prostate. 2025 May; 85(6):531-540.
Score: 0.056
-
Finati M, Stephens A, Cirulli GO, Chiarelli G, Tinsley S, Morrison C, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Rogers C, Carrieri G, Abdollah F. Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohort. JNCI Cancer Spectr. 2024 Nov 01; 8(6).
Score: 0.055
-
Finati M, Davis M, Stephens A, Chiarelli G, Cirulli GO, Morrison C, Affas R, Sood A, Buffi N, Lughezzani G, Briganti A, Montorsi F, Carrieri G, Rogers C, Vickers AJ, Abdollah F. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort. Eur Urol Oncol. 2024 Dec; 7(6):1535-1542.
Score: 0.054
-
Corsi NJ, Stephens A, Finati M, Malchow T, Morrison C, Davis M, Hares K, Corsi MP, Arora S, Chiarelli G, Cirulli GO, Autorino R, Sood A, Rogers C, Abdollah F. Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort. Urol Oncol. 2024 06; 42(6):175.e19-175.e25.
Score: 0.053
-
Chiarelli G, Davis M, Stephens A, Cirulli GO, Finati M, Corsi NJ, Sood A, Tinsley S, Carrieri G, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Comparison of patient background between a real-world North American cohort and the G?teborg-2 trial. Int J Urol. 2024 May; 31(5):562-567.
Score: 0.053
-
Rakic N, Sood A, Dalela D, Arora S, Malovana U, Keeley J, Rogers C, Peabody J, Menon M, Abdollah F. A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients. Clin Genitourin Cancer. 2020 12; 18(6):489-499.e6.
Score: 0.041
-
Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018 03; 121(3):345-347.
Score: 0.034